Providing a diverse range of perspectives from bullish to bearish, 12 analysts have published ratings on JPMorgan Chase JPM in the last three months.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 9 | 3 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 1 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 7 | 2 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $222.17, a high estimate of $235.00, and a low estimate of $211.00. Witnessing a positive shift, the current average has risen by 2.99% from the previous average price target of $215.73.
Understanding Analyst Ratings: A Comprehensive Breakdown
In examining recent analyst actions, we gain insights into how financial experts perceive JPMorgan Chase. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Chris Kotowski | Oppenheimer | Raises | Outperform | $234.00 | $221.00 |
| Betsy Graseck | Morgan Stanley | Lowers | Overweight | $220.00 | $226.00 |
| Matt O'Connor | Deutsche Bank | Announces | Hold | $235.00 | - |
| Betsy Graseck | Morgan Stanley | Raises | Overweight | $226.00 | $221.00 |
| Glenn Schorr | Evercore ISI Group | Raises | Outperform | $211.00 | $210.00 |
| Keith Horowitz | Citigroup | Raises | Neutral | $215.00 | $205.00 |
| Mike Mayo | Wells Fargo | Raises | Overweight | $225.00 | $220.00 |
| Scott Siefers | Piper Sandler | Raises | Overweight | $230.00 | $220.00 |
| Jason Goldberg | Barclays | Raises | Overweight | $217.00 | $212.00 |
| Chris Kotowski | Oppenheimer | Raises | Outperform | $221.00 | $215.00 |
| Betsy Graseck | Morgan Stanley | Raises | Overweight | $221.00 | $214.00 |
| David Konrad | Keefe, Bruyette & Woods | Raises | Market Perform | $211.00 | $209.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to JPMorgan Chase. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of JPMorgan Chase compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of JPMorgan Chase's stock. This comparison reveals trends in analysts' expectations over time.
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of JPMorgan Chase's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on JPMorgan Chase analyst ratings.
Get to Know JPMorgan Chase Better
JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with nearly $4.1 trillion in assets. It is organized into four major segments--consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates, and is subject to regulation, in multiple countries.
A Deep Dive into JPMorgan Chase's Financials
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: JPMorgan Chase displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 29.74%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: JPMorgan Chase's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 35.39%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): JPMorgan Chase's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.68% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): JPMorgan Chase's ROA stands out, surpassing industry averages. With an impressive ROA of 0.43%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 1.39, JPMorgan Chase adopts a prudent financial strategy, indicating a balanced approach to debt management.
Analyst Ratings: What Are They?
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
